Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Income margin | 19.8% | 19.5% | 9.1% | 17.7% | 19.3% | 20.3% | 17.3% | 14.8% | 20.3% | 12.0% | 12.8% | 14.1% | 15.3% | 6.3% | 11.9% | 14.2% | 15.5% | 19.6% | 19.2% | 16.2% |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, Microsoft Corp's last 12-month Operating Income margin is 16.7%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Operating Income margin for Abbott Laboratories have been 18.4% over the past three years, and 18.0% over the past five years.
As of today, Abbott Laboratories's Operating Income margin is 16.7%, which is higher than industry median of (32.3%). It indicates that Abbott Laboratories's Operating Income margin is Good.